Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1hwk | ADP | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1hwk | ADP | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 1.000 | |
| 1hwj | ADP | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.618 | |
| 1hw8 | ADP | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.576 | |
| 2q1l | 882 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.483 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.473 | |
| 1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.456 | |
| 4c7k | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.452 | |
| 2npa | MMB | Peroxisome proliferator-activated receptor alpha | / | 0.450 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.449 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.449 | |
| 5hws | NAP | 2-dehydropantoate 2-reductase | / | 0.449 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.445 | |
| 3dys | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.445 | |
| 1qor | NDP | Quinone oxidoreductase 1 | / | 0.444 | |
| 2qta | TDP | Pyruvate dehydrogenase E1 component | 1.2.4.1 | 0.444 | |
| 3b7d | CNI | Glutamate receptor 2 | / | 0.443 | |
| 3gvh | NAD | Malate dehydrogenase | / | 0.443 | |
| 4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.440 |